Search Report
Home   About Us   Press Room   Custom Research   Research Store   Contact Us
Press Releases

 

India’s APIs Domestic Industry losing on to China’s Cheap APIs Imports

Jun 15, 2011
Share |
 
As per our new research report Global API Market Analysis, there has been a sharp fall in the share of India’s domestic APIs production. It has been observed that, most active pharmaceutical ingredients (API) are being imported from China. As a result, the government is in favor of policy interventions to bring back bulk drug manufacturing to India. Various measures, such as tax incentives and provision of soft loans have to be put in place to encourage investments so that production rises and jobs are generated in the Indian APIs industry.
 
Our study indicates that, in the coming years, the Indian domestic bulk drugs industry can benefit from the impending patent expiries, including those of blockbuster drugs, in the regulated markets. This will open up opportunities for supplying bulk drugs to manufacturers of such generic drugs as well as increase outsourcing of bulk drugs by multinational pharmaceutical companies.
 
Besides, we have done thorough research and prudent analysis of the global APIs industry and identified some critical factors acting as a catalyst for the industry’s current and future growth outlook. The report reveals that, the APIs industry is in best spirits now and is looking forward to a stupendous growth in the coming years. The global APIs grew at a CAGR of around 8 % during 2005 - 2010. Based on some concrete market fundamentals, we anticipate that, generics prescription drugs and biotech APIs will experience tremendous growth in future driven by increased demand from the pharmaceutical industry.
 
Global API Market Analysis, analyzes the global APIs industry, by segmenting it into biotech, synthetic, prescription, and generics APIs. Each of these segments have been thoroughly studied and analyzed in the report. A separate section on the emerging opportunities from High Potency APIs has also been covered separately in the report. Moreover, the report provides an overview of the industry challenges & regulatory environment, which will help clients in identifying the future demand scenario.
 
The research contains exhaustive information regarding the market players, recent developments, and geographical markets that will help clients in formulating market strategies and assess opportunity areas in the global APIs market.

For more information visit: http://www.rncos.com/Report/IM320.htm

Related Press Releases:
» Personalized Medicine Market Foraying Marvelous Growth in the US
» Middle East and Africa Pharma Sector to Grow at 9.5% CAGR
» Global Pharma Industry: All Set for a Boom
» E7 Pharma Market Poised with Stupendous Growth
» China Pharmaceutical Market to Grow at 20% CAGR
 
Related Research Reports
Related Research News
May 03, 2010
New Product Launches Led US Pharma Market to Grow Strongly in 2009
Apr 30, 2010
India to be Among Top 10 Drug Producers by 2020
Apr 05, 2010
China ? On the Way to Become Third Largest Pharma Market
Jan 25, 2010
Indian Government to Set Up Special Zones to Boost Pharma Exports
Phone : +91 (120) 4224700/01/02/03
Fax : +91 (120) 4224707

Copyright © 2011, RNCOS, 2002-2011

Home
About Us
Careers
Request a Quote
Discounted Reports
Contact Us
Add URL
FAQ
Upcoming Reports